Legal professionals in the corporate field and especially those in the healthcare industry might be intrigued by recent developments in insurance law. This August, a working group sponsored by the National Association of Insurance Commissioners (NAIC) unanimously approved revisions to the NAIC’s Unfair Trade Practices Act Model #880. This legislative model, more commonly referred to as the “Model Law,” plays a significant role in the regulation and practices of the health insurance industry.
The primary purpose of these revisions is to curb any improper marketing of health insurance products. The changes aim to provide state healthcare regulators with a broader authority over health insurance lead generators. Lead generators, in this context, refers to businesses that gather and sell personal information to companies marching the data, in this instance, health insurance providers. These changes, it seems, would create a more vigorous regulatory framework, ensuring a heightened level of consumer protection in the sector.
An exciting aspect of these revisions is their unanimous approval by the working group. Unanimity suggests a strong belief in the necessity and efficacy of these changes across the board.
For more details on the revisions to the Model Law, follow up here. The summarised report, published by Venable LLP, offers a more detailed outline of the issues at hand and the potential impact these changes could have on the insurance industry.
Staying abreast of these developments and understanding the potential implications are essential aspects of corporate legal practice, particularly for those involved in healthcare and insurance. The revisions to the Model Law could lead to substantial changes in tactics used by lead generators, which could imbue significant shifts within the practices of health insurance marketing.